Report an error

Spotted something inaccurate in “Tirzepatide Cuts Major Kidney Events ~21% vs. Dulaglutide in High-Risk CKD (Exploratory Analysis)”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.